Core Points - Shanghai Xiaofang Pharmaceutical Co., Ltd. has announced a change in the continuous supervision sponsor representative for its initial public offering (IPO) project [1] - The original representatives, Chen Zhenyu and Liu Yaxin, will be succeeded by Chen Sheng due to Chen Zhenyu's work relocation [1] - The change will not affect the ongoing supervision work by Guosen Securities [1] Summary by Sections Company Announcement - The board of directors of Shanghai Xiaofang Pharmaceutical guarantees the truthfulness, accuracy, and completeness of the announcement [1] - Guosen Securities has issued a letter regarding the designation of the continuous supervision sponsor representative for the company's IPO [1] Personnel Changes - Chen Zhenyu will no longer serve as the continuous supervision sponsor representative due to work changes [1] - Chen Sheng has been appointed to replace Chen Zhenyu, alongside Liu Yaxin, as the new representatives for the IPO project [1] Acknowledgment - The board expresses gratitude for Chen Zhenyu's contributions during his tenure as the sponsor representative [1]
上海小方制药股份有限公司 关于更换持续督导保荐代表人的公告